{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T15:32:03Z","timestamp":1793460723748,"version":"4.5.0"},"reference-count":63,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T00:00:00Z","timestamp":1791504000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T00:00:00Z","timestamp":1791504000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Mol Immunol"],"DOI":"10.1038\/s41423-026-01472-1","type":"journal-article","created":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T03:10:10Z","timestamp":1791515410000},"page":"1457-1472","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Geranylgeranylation is required for B-cell proliferation and plasma cell survival implications for autoimmune therapy"],"prefix":"10.1038","volume":"23","author":[{"given":"Lai","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haoyuan","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiayi","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shangru","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shumei","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiao","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junhui","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qilin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyu","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenrui","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meiling","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7749-9618","authenticated-orcid":false,"given":"Qianjin","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,9]]},"reference":[{"key":"1472_CR1","doi-asserted-by":"crossref","unstructured":"Lazar S, Kahlenberg JM. Systemic Lupus Erythematosus: New Diagnostic and Therapeutic Approaches. Annu Rev Med. 2023;74:339\u2013352.","DOI":"10.1146\/annurev-med-043021-032611"},{"key":"1472_CR2","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1016\/j.molmed.2017.05.006","volume":"23","author":"VR Molton","year":"2017","unstructured":"Molton VR, Suarez-Fueyo A, Meidan E, Li H, Mizui M, Tsokos GC. Pathogenesis of Human Systemic Lupus Erythematosus: A Cellular Perspective. Trends Mol Med. 2017;23:615\u201335.","journal-title":"Trends Mol Med"},{"key":"1472_CR3","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1056\/NEJMoa2023325","volume":"383","author":"L Ostendorf","year":"2020","unstructured":"Ostendorf L, Burns M, Durek P, Heinz GA, Heinrich F, Garantziotis P, et al. Targeting CD38 with Daratumumab in Refractory Systemic Lupus Erythematosus. N Engl J Med. 2020;383:1149\u201355.","journal-title":"N Engl J Med"},{"key":"1472_CR4","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.jaut.2012.05.010","volume":"39","author":"IM Mumtaz","year":"2012","unstructured":"Mumtaz IM, Hoyer BF, Panne D, Moser K, Winter O, Cheng QY, et al. Bone marrow of NZB\/W mice is the major site for plasma cells resistant to dexamethasone and cyclophosphamide: implications for the treatment of autoimmunity. J Autoimmun. 2012;39:180\u20138.","journal-title":"J Autoimmun"},{"key":"1472_CR5","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1038\/ni1149","volume":"6","author":"JW Brewer","year":"2005","unstructured":"Brewer JW, Hendershot LM. Building an antibody factory: a job for the unfolded protein response. Nat Immunol. 2005;6:23\u20139.","journal-title":"Nat Immunol"},{"key":"1472_CR6","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1038\/ni.3348","volume":"17","author":"J Tellier","year":"2016","unstructured":"Tellier J, Shi W, Minnich M, Liao Y, Crawford S, Smyth GK, et al. Blimp-1 controls plasma cell function through the regulation of immunoglobulin secretion and the unfolded protein response. Nat Immunol. 2016;17:323\u201330.","journal-title":"Nat Immunol"},{"key":"1472_CR7","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1111\/imr.13012","volume":"303","author":"D Ricci","year":"2021","unstructured":"Ricci D, Gidalevitz T, Argon Y. The special unfolded protein response in plasma cells. Immunol Rev. 2021;303:35\u201351.","journal-title":"Immunol Rev"},{"key":"1472_CR8","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1038\/nrm2728","volume":"10","author":"H Stenmark","year":"2009","unstructured":"Stenmark H. Rab GTPases as coordinators of vesicle traffic. Nat Rev Mol Cell Biol. 2009;10:513\u201325.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"1472_CR9","doi-asserted-by":"publisher","first-page":"2801","DOI":"10.1007\/s00018-008-8351-4","volume":"65","author":"M Fukuda","year":"2008","unstructured":"Fukuda M. Regulation of secretory vesicle traffic by Rab small GTPases. Cell Mol Life Sci. 2008;65:2801\u201313.","journal-title":"Cell Mol Life Sci"},{"key":"1472_CR10","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1038\/76069","volume":"25","author":"J Schultz","year":"2000","unstructured":"Schultz J, Doerks T, Ponting CP, Copley RR, Bork P. More than 1,000 putative new human signaling proteins revealed by EST data mining. Nat Genet. 2000;25:201\u20134.","journal-title":"Nat Genet"},{"key":"1472_CR11","doi-asserted-by":"publisher","first-page":"1882","DOI":"10.1091\/mbc.e02-10-0639","volume":"14","author":"AQ Gomes","year":"2003","unstructured":"Gomes AQ, Ali BR, Ramalho JS, Godfrey RF, Barral DC, Hume AN, et al. Membrane targeting of Rab GTPases is influenced by the prenylation motif. Mol Biol Cell. 2003;14:1882\u201399.","journal-title":"Mol Biol Cell"},{"key":"1472_CR12","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1001\/jama.2022.13044","volume":"328","author":"CM Mangione","year":"2022","unstructured":"Mangione CM, Barry MJ, Nicholson WK, Cabana M, Chelmow D, Coker TR, et al. Statin Use for the Primary Prevention of Cardiovascular Disease in Adults: US Preventive Services Task Force Recommendation Statement. JAMA. 2022;328:746\u201353.","journal-title":"JAMA"},{"key":"1472_CR13","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1007\/s10565-020-09558-w","volume":"37","author":"L Wang","year":"2021","unstructured":"Wang L, Zheng ZG, Meng L, Zhu L, Li P, Chen J, et al. Statins induce skeletal muscle atrophy via GGPP depletion-dependent myostatin overexpression in skeletal muscle and brown adipose tissue. Cell Biol Toxicol. 2021;37:441\u201360.","journal-title":"Cell Biol Toxicol"},{"key":"1472_CR14","doi-asserted-by":"publisher","first-page":"114915","DOI":"10.1016\/j.biopha.2023.114915","volume":"164","author":"D Jung","year":"2023","unstructured":"Jung D, Bachmann HS. Regulation of protein prenylation. Biomed Pharmacother. 2023;164:114915.","journal-title":"Biomed Pharmacother"},{"key":"1472_CR15","doi-asserted-by":"publisher","first-page":"2697","DOI":"10.1002\/jcsm.13061","volume":"13","author":"L Wang","year":"2022","unstructured":"Wang L, Zheng Z, Zhu L, Meng L, Liu H, Wang K, et al. Geranylgeranyl pyrophosphate depletion by statins compromises skeletal muscle insulin sensitivity. J Cachexia Sarcopenia Muscle. 2022;13:2697\u2013711.","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"1472_CR16","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1038\/s43018-022-00358-1","volume":"3","author":"C Guo","year":"2022","unstructured":"Guo C, Wan R, He Y, Lin SH, Cao J, Qiu Y, et al. Therapeutic targeting of the mevalonate-geranylgeranyl diphosphate pathway with statins overcomes chemotherapy resistance in small cell lung cancer. Nat Cancer. 2022;3:614\u201328. p.","journal-title":"Nat Cancer"},{"key":"1472_CR17","doi-asserted-by":"publisher","first-page":"155120","DOI":"10.1016\/j.metabol.2021.155120","volume":"128","author":"L Wang","year":"2022","unstructured":"Wang L, Zhu L, Zheng Z, Meng L, Liu H, Wang K, et al. Mevalonate pathway orchestrates insulin signaling via RAB14 geranylgeranylation-mediated phosphorylation of AKT to regulate hepatic glucose metabolism. Metabolism. 2022;128:155120.","journal-title":"Metabolism"},{"key":"1472_CR18","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1038\/s41590-022-01376-y","volume":"24","author":"W Luo","year":"2023","unstructured":"Luo W, Adamska JZ, Li C, Verma R, Liu Q, Hagan T, et al. SREBP signaling is essential for effective B-cell responses. Nat Immunol. 2023;24:337\u201348.","journal-title":"Nat Immunol"},{"key":"1472_CR19","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1038\/s41590-020-0743-0","volume":"21","author":"D Nehar-Belaid","year":"2020","unstructured":"Nehar-Belaid D, Hong S, Marches R, Chen G, Bolisetty M, Baisch J, et al. Mapping systemic lupus erythematosus heterogeneity at the single-cell level. Nat Immunol. 2020;21:1094\u2013106.","journal-title":"Nat Immunol"},{"key":"1472_CR20","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1002\/j.1552-4604.1992.tb05773.x","volume":"32","author":"FL Tse","year":"1992","unstructured":"Tse FL, Jaffe JM, Troendle A. Pharmacokinetics of fluvastatin after single and multiple doses in normal volunteers. J Clin Pharmacol. 1992;32:630\u20138.","journal-title":"J Clin Pharmacol"},{"key":"1472_CR21","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.curtheres.2015.02.001","volume":"77","author":"Z Luo","year":"2015","unstructured":"Luo Z, Zhang Y, Gu J, Feng P, Wang Y. Pharmacokinetic Properties of Single- and Multiple-Dose Pitavastatin Calcium Tablets in Healthy Chinese Volunteers. Curr Ther Res Clin Exp. 2015;77:52\u20137.","journal-title":"Curr Ther Res Clin Exp"},{"key":"1472_CR22","doi-asserted-by":"publisher","first-page":"eabj2797","DOI":"10.1126\/sciadv.abj2797","volume":"8","author":"WY Shen","year":"2022","unstructured":"Shen WY, Luo C, Hurtado PR, Liu XJ, Luo RY, Li H, et al. Upregulation of proBDNF\/p75(NTR) signaling in antibody-secreting cells drives systemic lupus erythematosus. Sci Adv. 2022;8:eabj2797.","journal-title":"Sci Adv"},{"key":"1472_CR23","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/j.coi.2005.03.003","volume":"17","author":"SL Peng","year":"2005","unstructured":"Peng SL. Signaling in B cells via Toll-like receptors. Curr Opin Immunol. 2005;17:230\u20136.","journal-title":"Curr Opin Immunol"},{"key":"1472_CR24","doi-asserted-by":"publisher","first-page":"1358","DOI":"10.1038\/s41590-023-01540-y","volume":"24","author":"R Sharma","year":"2023","unstructured":"Sharma R, Smolkin RM, Chowdhury P, Fernandez KC, Kim Y, Cols M, et al. Distinct metabolic requirements regulate B-cell activation and germinal center responses. Nat Immunol. 2023;24:1358\u201369.","journal-title":"Nat Immunol"},{"key":"1472_CR25","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.1038\/ni.3519","volume":"17","author":"BG Barwick","year":"2016","unstructured":"Barwick BG, Scharer CD, Bally APR, Boss JM. Plasma cell differentiation is coupled to division-dependent DNA hypomethylation and gene regulation. Nat Immunol. 2016;17:1216\u201325.","journal-title":"Nat Immunol"},{"key":"1472_CR26","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1016\/j.immuni.2019.04.011","volume":"50","author":"S Crotty","year":"2019","unstructured":"Crotty S. T Follicular Helper Cell Biology: A Decade of Discovery and Diseases. Immunity. 2019;50:1132\u201348.","journal-title":"Immunity"},{"key":"1472_CR27","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1038\/s41590-019-0427-9","volume":"20","author":"K Kwak","year":"2019","unstructured":"Kwak K, Akkaya M, Pierce SK. B-cell signaling in context. Nat Immunol. 2019;20:963\u20139.","journal-title":"Nat Immunol"},{"key":"1472_CR28","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1038\/sj.cr.7290047","volume":"10","author":"D Donjerkovi\u0107","year":"2000","unstructured":"Donjerkovi\u0107 D, Scott DW. Activation-induced cell death in B lymphocytes. Cell Res. 2000;10:179\u201392.","journal-title":"Cell Res"},{"key":"1472_CR29","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/j.immuni.2018.01.008","volume":"48","author":"W Luo","year":"2018","unstructured":"Luo W, Weisel F, Shlomchik MJ. B-Cell Receptor and CD40 Signaling Are Rewired for Synergistic Induction of the c-Myc Transcription Factor in Germinal Center B Cells. Immunity. 2018;48:313\u2013326.e5.","journal-title":"Immunity"},{"key":"1472_CR30","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/j.immuni.2011.01.011","volume":"34","author":"B Hou","year":"2011","unstructured":"Hou B, Saudan P, Ott G, Wheeler ML, Ji M, Kuzmich L, et al. Selective utilization of Toll-like receptor and MyD88 signaling in B cells for enhancement of the antiviral germinal center response. Immunity. 2011;34:375\u201384.","journal-title":"Immunity"},{"key":"1472_CR31","doi-asserted-by":"crossref","unstructured":"Zhang X, Ma C, Lu Y, Wang J, Yun H, Jiang H, et al. Rack1 regulates B-cell development and function by binding to and stabilizing the transcription factor Pax5. Cell Mol Immunol. 2024;21:1282\u20131295.","DOI":"10.1038\/s41423-024-01213-2"},{"key":"1472_CR32","doi-asserted-by":"crossref","unstructured":"Steach HR, York AG, Skadow MH, Chen S, Zhao J, Williams KJ, et al., IL-4 Licenses B-Cell Activation Through Cholesterol Synthesis. bioRxiv. 2024;2024.05.13.593964.","DOI":"10.1101\/2024.05.13.593964"},{"key":"1472_CR33","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1038\/nri2172","volume":"7","author":"AM Scharenberg","year":"2007","unstructured":"Scharenberg AM, Humphries LA, Rawlings DJ. Calcium signaling and cell-fate choice in B cells. Nat Rev Immunol. 2007;7:778\u201389.","journal-title":"Nat Rev Immunol"},{"key":"1472_CR34","doi-asserted-by":"publisher","first-page":"3777","DOI":"10.4049\/jimmunol.181.6.3777","volume":"181","author":"Q Yu","year":"2008","unstructured":"Yu Q, Quinn WJ 3rd, Salay T, Crowley JE, Cancro MP, Sen JM. Role of beta-catenin in B-cell development and function. J Immunol. 2008;181:3777\u201383.","journal-title":"J Immunol"},{"key":"1472_CR35","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1038\/s41590-018-0156-5","volume":"19","author":"M Akkaya","year":"2018","unstructured":"Akkaya M, Traba J, Roesler AS, Miozzo P, Akkaya B, Theall BP, et al. Second signals rescue B cells from activation-induced mitochondrial dysfunction and death. Nat Immunol. 2018;19:871\u201384.","journal-title":"Nat Immunol"},{"key":"1472_CR36","doi-asserted-by":"publisher","first-page":"3375","DOI":"10.1016\/j.cell.2022.07.021","volume":"185","author":"M Nakano","year":"2022","unstructured":"Nakano M, Ota M, Takeshima Y, Iwasaki Y, Hatano H, Nagafuchi Y, et al. Distinct transcriptome architectures underlying lupus establishment and exacerbation. Cell. 2022;185:3375\u20133389.e21.","journal-title":"Cell"},{"key":"1472_CR37","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1002\/art.38298","volume":"66","author":"M Yokogawa","year":"2014","unstructured":"Yokogawa M, Takaishi M, Nakajima K, Kamijima R, Fujimoto C, Kataoka S, et al. Epicutaneous application of toll-like receptor 7 agonists leads to systemic autoimmunity in wild-type mice: a new model of systemic Lupus erythematosus. Arthritis Rheumatol. 2014;66:694\u2013706.","journal-title":"Arthritis Rheumatol"},{"key":"1472_CR38","doi-asserted-by":"publisher","first-page":"2403","DOI":"10.1007\/s10067-017-3811-6","volume":"36","author":"EC Freitas","year":"2017","unstructured":"Freitas EC, de Oliveira MS, Monticielo OA. Pristane-induced lupus: considerations on this experimental model. Clin Rheumatol. 2017;36:2403\u201314.","journal-title":"Clin Rheumatol"},{"key":"1472_CR39","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1177\/0961203316662719","volume":"26","author":"R Castejon","year":"2017","unstructured":"Castejon R, Casta\u00f1eda A, Sollet A, Mellor-Pita S, Tutor-Ureta P, Jimenez-Ortiz C, et al. Short-term atorvastatin therapy improves arterial stiffness of middle-aged systemic lupus erythematosus patients with pathological pulse wave velocity. Lupus. 2017;26:355\u201364.","journal-title":"Lupus"},{"key":"1472_CR40","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1016\/j.autrev.2015.12.007","volume":"15","author":"A Sahebkar","year":"2016","unstructured":"Sahebkar A, Rathouska J, Derosa G, Maffioli P, Nachtigal P. Statin impact on disease activity and C-reactive protein concentrations in systemic lupus erythematosus patients: A systematic review and meta-analysis of controlled trials. Autoimmun Rev. 2016;15:344\u201353.","journal-title":"Autoimmun Rev"},{"key":"1472_CR41","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1136\/annrheumdis-2016-209850","volume":"76","author":"C Rozo","year":"2017","unstructured":"Rozo C, Chinenov Y, Maharaj RK, Gupta S, Leuenberger L, Kirou KA, et al. Targeting the RhoA-ROCK pathway to reverse T-cell dysfunction in SLE. Ann Rheum Dis. 2017;76:740\u20137.","journal-title":"Ann Rheum Dis"},{"key":"1472_CR42","doi-asserted-by":"publisher","first-page":"7416","DOI":"10.4049\/jimmunol.177.10.7416","volume":"177","author":"EC Jury","year":"2006","unstructured":"Jury EC, Isenberg DA, Mauri C, Ehrenstein MR. Atorvastatin restores Lck expression and lipid raft-associated signaling in T cells from patients with systemic lupus erythematosus. J Immunol. 2006;177:7416\u201322.","journal-title":"J Immunol"},{"key":"1472_CR43","doi-asserted-by":"crossref","unstructured":"Wang L, Jiang J, Yin H, Wu J, Su X, Meng L, et al., Modulation of the mevalonate pathway by TCR engagement regulates T follicular helper cell generation in homeostasis and autoimmunity. Immunity, 2026.","DOI":"10.1016\/j.immuni.2026.04.009"},{"key":"1472_CR44","doi-asserted-by":"publisher","first-page":"5294","DOI":"10.4049\/jimmunol.1203436","volume":"193","author":"A Shimabukuro-Vornhagen","year":"2014","unstructured":"Shimabukuro-Vornhagen A, Zoghi S, Liebig TM, Wennhold K, Chemitz J, Draube A, et al. Inhibition of protein geranylgeranylation specifically interferes with CD40-dependent B-cell activation, resulting in a reduced capacity to induce T-cell immunity. J Immunol. 2014;193:5294\u2013305.","journal-title":"J Immunol"},{"key":"1472_CR45","doi-asserted-by":"publisher","first-page":"2885","DOI":"10.1002\/eji.200636567","volume":"36","author":"R Ghittoni","year":"2006","unstructured":"Ghittoni R, Napolitani G, Benati D, Ulivieri C, Patrussi L, Laghi Pasini F, et al. Simvastatin inhibits the MHC class II pathway of antigen presentation by impairing Ras superfamily GTPases. Eur J Immunol. 2006;36:2885\u201393.","journal-title":"Eur J Immunol"},{"key":"1472_CR46","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1016\/j.cell.2018.08.070","volume":"175","author":"Y Xia","year":"2018","unstructured":"Xia Y, Xie Y, Yu Z, Xiao H, Jiang G, Zhou X, et al. The Mevalonate Pathway Is a Druggable Target for Vaccine Adjuvant Discovery. Cell. 2018;175:1059\u20131073.e21.","journal-title":"Cell"},{"key":"1472_CR47","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1038\/nrd1901","volume":"4","author":"MK Jain","year":"2005","unstructured":"Jain MK, Ridker PM. Anti-inflammatory effects of statins: clinical evidence and basic mechanisms. Nat Rev Drug Discov. 2005;4:977\u201387.","journal-title":"Nat Rev Drug Discov"},{"key":"1472_CR48","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1007\/s12016-020-08791-9","volume":"60","author":"K Koushki","year":"2021","unstructured":"Koushki K, Shahbaz SK, Mashayekhi K, Sadeghi M, Zayeri ZD, Taba MY, et al. Anti-inflammatory Action of Statins in Cardiovascular Disease: the Role of Inflammasome and Toll-Like Receptor Pathways. Clin Rev Allergy Immunol. 2021;60:175\u201399.","journal-title":"Clin Rev Allergy Immunol"},{"key":"1472_CR49","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1038\/nrrheum.2011.1","volume":"7","author":"F Hiepe","year":"2011","unstructured":"Hiepe F, D\u00f6rner T, Hauser AE, Hoyer BF, Mei H, Radbruch A. Long-lived autoreactive plasma cells drive persistent autoimmune inflammation. Nat Rev Rheumatol. 2011;7:170\u20138.","journal-title":"Nat Rev Rheumatol"},{"key":"1472_CR50","doi-asserted-by":"publisher","first-page":"1965","DOI":"10.1007\/s10067-023-06559-y","volume":"42","author":"RF Modica","year":"2023","unstructured":"Modica RF, Thatayatikom A, Bell-Brunson DH, Elder ME. Bortezomib is efficacious in the treatment of severe childhood-onset neuropsychiatric systemic lupus erythematosus with psychosis: a case series and mini-review of B-cell immunomodulation in antibody-mediated diseases. Clin Rheumatol. 2023;42:1965\u201379.","journal-title":"Clin Rheumatol"},{"key":"1472_CR51","doi-asserted-by":"publisher","first-page":"1474","DOI":"10.1136\/annrheumdis-2014-206016","volume":"74","author":"T Alexander","year":"2015","unstructured":"Alexander T, Sarfert R, Klotsche J, K\u00fchl AA, Rubbert-Roth A, Lorenz HM, et al. The proteasome inhibitior bortezomib depletes plasma cells and ameliorates clinical manifestations of refractory systemic lupus erythematosus. Ann Rheum Dis. 2015;74:1474\u20138.","journal-title":"Ann Rheum Dis"},{"key":"1472_CR52","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1038\/nature25486","volume":"554","author":"YC Wong","year":"2018","unstructured":"Wong YC, Ysselstein D, Krainc D. Mitochondria-lysosome contacts regulate mitochondrial fission via RAB7 GTP hydrolysis. Nature. 2018;554:382\u20136.","journal-title":"Nature"},{"key":"1472_CR53","doi-asserted-by":"publisher","first-page":"1888","DOI":"10.1136\/annrheumdis-2013-203794","volume":"73","author":"TN Caza","year":"2014","unstructured":"Caza TN, Fernandez DR, Talaber G, Oaks Z, Haas M, Madaio MP, et al. HRES-1\/Rab4-mediated depletion of Drp1 impairs mitochondrial homeostasis and represents a target for treatment in SLE. Ann Rheum Dis. 2014;73:1888\u201397.","journal-title":"Ann Rheum Dis"},{"key":"1472_CR54","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1042\/bj3380123","volume":"338","author":"LA Perrin-Cocon","year":"1999","unstructured":"Perrin-Cocon LA, Marche PN, Villiers CL. Purification of intracellular compartments involved in antigen processing: a new method based on magnetic sorting. Biochem J. 1999;338:123\u201330.","journal-title":"Biochem J"},{"key":"1472_CR55","doi-asserted-by":"publisher","first-page":"1769","DOI":"10.1084\/jem.188.10.1769","volume":"188","author":"DA Lazzarino","year":"1998","unstructured":"Lazzarino DA, Blier P, Mellman I. The monomeric guanosine triphosphatase rab4 controls an essential step on the pathway of receptor-mediated antigen processing in B cells. J Exp Med. 1998;188:1769\u201374.","journal-title":"J Exp Med"},{"key":"1472_CR56","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1093\/intimm\/14.3.309","volume":"14","author":"EM Bertram","year":"2002","unstructured":"Bertram EM, Hawley RG, Watts TH. Overexpression of rab7 enhances the kinetics of antigen processing and presentation with MHC class II molecules in B cells. Int Immunol. 2002;14:309\u201318. p.","journal-title":"Int Immunol"},{"key":"1472_CR57","doi-asserted-by":"crossref","unstructured":"Runsala M, Kuokkanen E, Uski E, \u0160u\u0161tar V, Balci M, Rajala J, et al. The Small GTPase Rab7 Regulates Antigen Processing in B Cells in a Possible Interplay with Autophagy Machinery. Cells. 2023;12:2566.","DOI":"10.3390\/cells12212566"},{"key":"1472_CR58","doi-asserted-by":"publisher","first-page":"3065","DOI":"10.4049\/jimmunol.1401896","volume":"194","author":"EJ Pone","year":"2015","unstructured":"Pone EJ, Lam T, Lou Z, Wang R, Chen Y, Liu D, et al. B-cell Rab7 mediates induction of activation-induced cytidine deaminase expression and class-switching in T-dependent and T-independent antibody responses. J Immunol. 2015;194:3065\u201378.","journal-title":"J Immunol"},{"key":"1472_CR59","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.4049\/jimmunol.1901170","volume":"204","author":"H Yan","year":"2020","unstructured":"Yan H, Fernandez M, Wang J, Wu S, Wang R, Lou Z, et al. B-Cell Endosomal RAB7 Promotes TRAF6 K63 Polyubiquitination and NF-\u03baB Activation for Antibody Class-Switching. J Immunol. 2020;204:1146\u201357.","journal-title":"J Immunol"},{"key":"1472_CR60","doi-asserted-by":"publisher","first-page":"3792","DOI":"10.4049\/jimmunol.1601427","volume":"197","author":"T Lam","year":"2016","unstructured":"Lam T, Kulp DV, Wang R, Lou Z, Taylor J, Rivera CE, et al. Small Molecule Inhibition of Rab7 Impairs B-Cell Class Switching and Plasma Cell Survival To Dampen the Autoantibody Response in Murine Lupus. J Immunol. 2016;197:3792\u2013805.","journal-title":"J Immunol"},{"key":"1472_CR61","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-46441-2","volume":"15","author":"N Huang","year":"2024","unstructured":"Huang N, Winans T, Wyman B, Oaks Z, Faludi T, Choudhary G, et al. Rab4A-directed endosome traffic shapes pro-inflammatory mitochondrial metabolism in T cells via mitophagy, CD98 expression, and kynurenine-sensitive mTOR activation. Nat Commun. 2024;15:2598.","journal-title":"Nat Commun"},{"key":"1472_CR62","doi-asserted-by":"publisher","first-page":"1725","DOI":"10.1002\/art.1780400928","volume":"40","author":"MC Hochberg","year":"1997","unstructured":"Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1997;40:1725.","journal-title":"Arthritis Rheum"},{"key":"1472_CR63","doi-asserted-by":"publisher","first-page":"4560","DOI":"10.1016\/j.apsb.2024.06.024","volume":"14","author":"L Wang","year":"2024","unstructured":"Wang L, Yin H, Jiang J, Li Q, Gao C, Li W, et al. A rationally designed CD19 monoclonal antibody-triptolide conjugate for the treatment of systemic lupus erythematosus. Acta Pharm Sin B. 2024;14:4560\u201376.","journal-title":"Acta Pharm Sin B"}],"container-title":["Cellular &amp; Molecular Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41423-026-01472-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41423-026-01472-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41423-026-01472-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T15:10:00Z","timestamp":1793459400000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41423-026-01472-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,9]]},"references-count":63,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2026,11]]}},"alternative-id":["1472"],"URL":"https:\/\/doi.org\/10.1038\/s41423-026-01472-1","relation":{},"ISSN":["2042-0226"],"issn-type":[{"value":"2042-0226","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,9]]},"assertion":[{"value":"3 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no conflicts of interest. Qianjin.L. is an editorial board member of Cellular & Molecular Immunology, but he has not been involved in peer review or decision-making related to the article.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}]}}